Under lithium carbonate administration, nicotine triggers cell dysfunction in human glioblastoma U‑251MG cells, which is distinct from cotinine

Kato,Shinya

doi:10.3892/mi.2022.44

Under lithium carbonate administration, nicotine triggers cell dysfunction in human glioblastoma U‑251MG cells, which is distinct from cotinine

Authors:
- Shinya Kato
View Affiliations

Affiliations: Radioisotope Experimental Facility, Advanced Science Research Promotion Center, Mie University, Tsu, Mie 514‑8507, Japan
Published online on: May 31, 2022 https://doi.org/10.3892/mi.2022.44
Article Number: 19
Copyright: © Kato . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nicotine is an alkaloid found in tobacco leaves. Smoking prevention has been a neglected issue in psychiatry; nicotine intake in conjunction with the administration of the mood stabilizer, lithium carbonate (Li₂CO₃), may negatively affect brain cells. The present study investigated the combined effects of nicotine and its metabolite, cotinine, and Li₂CO₃ compared to acetylcholine and dopamine in U‑251MG human glioblastoma cells. Cell proliferation was found to be decreased by nicotine and to be further suppressed following treatment with Li₂CO₃, accompanied by mitotic catastrophe and increased levels of superoxide anion radicals. By contrast, cotinine did not exert such detrimental effects. It was also found that acetylcholine did not suppress cell proliferation, whereas dopamine in conjunction with Li₂CO₃ decreased cell proliferation in a concentration‑dependent manner. The nicotine‑induced cell growth inhibition was restored by mecamylamine, a non‑competitive antagonist of nicotinic acetylcholine receptors. On the whole, the findings of the present study suggest that nicotine combined with Li₂CO₃ leads to the suppression of the proliferation of human glioblastoma cells accompanied by mitotic catastrophe and superoxide anion radical generation. These findings may provide further cellular biological insight into the risks associated with smoking under Li₂CO₃ administration.

View Figures

View References

1	Glassman AH: Cigarette smoking: Implications for psychiatric illness. Am J Psychiatry. 150:546–553. 1993.PubMed/NCBI View Article : Google Scholar
2	Balfour DJ and Fagerstrom KO: Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther. 72:51–81. 1996.PubMed/NCBI View Article : Google Scholar
3	Lichtensteiger W, Hefti F, Felix D, Huwyler T, Melamed E and Schlumpf M: Stimulation of nigrostriatal dopamine neurones by nicotine. Neuropharmacology. 21:963–968. 1982.PubMed/NCBI View Article : Google Scholar
4	Hukkanen J, Jacob P III and Benowitz NL: Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 57:79–115. 2005.PubMed/NCBI View Article : Google Scholar
5	Henningfield JE and Zeller M: Nicotine psychopharmacology: Policy and regulatory. Handb Exp Pharmacol. 511-534:2009.PubMed/NCBI View Article : Google Scholar
6	Katner SN, Toalston JE, Smoker MP, Rodd ZA, McBride WJ and Engleman EA: Time-course of extracellular nicotine and cotinine levels in rat brain following administration of nicotine: Effects of route and ethanol coadministration. Psychopharmacology (Berl). 232:551–560. 2015.PubMed/NCBI View Article : Google Scholar
7	Young W: Review of lithium effects on brain and blood. Cell Transplant. 18:951–975. 2009.PubMed/NCBI View Article : Google Scholar
8	Kato S: Effects of platinum-coexisting dopamine with X-ray irradiation upon human glioblastoma cell proliferation. Hum Cell. 34:1653–1661. 2021.PubMed/NCBI View Article : Google Scholar
9	Bigner DD, Bigner SH, Ponten J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF and Wikstrand CJ: Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol. 40:201–229. 1981.PubMed/NCBI View Article : Google Scholar
10	Shulepko MA, Bychkov ML, Lyukmanova EN and Kirpichnikov MP: Recombinant analogue of the human protein SLURP-1 inhibits the growth of U251 MG and A172 glioma cells. Dokl Biochem Biophys. 493:211–214. 2020.PubMed/NCBI View Article : Google Scholar
11	Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y and Ueno K: A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull. 19:1518–1520. 1996.PubMed/NCBI View Article : Google Scholar
12	Milanovic D, Firat E, Grosu AL and Niedermann G: Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990. Radiat Oncol. 8(42)2013.PubMed/NCBI View Article : Google Scholar
13	Baehner RL and Nathan DG: Leukocyte oxidase: Defective activity in chronic granulomatous disease. Science. 155:835–836. 1967.PubMed/NCBI View Article : Google Scholar
14	Choi HS, Kim JW, Cha YN and Kim C: A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem. 27:31–44. 2006.PubMed/NCBI View Article : Google Scholar
15	Russell MA, Jarvis M, Iyer R and Feyerabend C: Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J. 280:972–976. 1980.PubMed/NCBI View Article : Google Scholar
16	Yasuda M, Ota T, Morikawa A, Mawatari K, Fukuuchi T, Yamaoka N, Kaneko K and Nakagomi K: Simultaneous determination of nicotine and cotinine in serum using high-performance liquid chromatography with fluorometric detection and postcolumn UV-photoirradiation system. J Chromatogr B Analyt Technol Biomed Life Sci. 934:41–45. 2013.PubMed/NCBI View Article : Google Scholar
17	Bowman ER, Turnbull LB and Mc KH Jr: Metabolism of nicotine in the human and excretion of pyridine compounds by smokers. J Pharmacol Exp Ther. 127:92–95. 1959.PubMed/NCBI
18	Benowitz NL, Kuyt F, Jacob P III, Jones RT and Osman AL: Cotinine disposition and effects. Clin Pharmacol Ther. 34:604–611. 1983.PubMed/NCBI View Article : Google Scholar
19	Riah O, Dousset JC, Courriere P, Stigliani JL, Baziard-Mouysset G and Belahsen Y: Evidence that nicotine acetylcholine receptors are not the main targets of cotinine toxicity. Toxicol Lett. 109:21–29. 1999.PubMed/NCBI View Article : Google Scholar
20	de Sousa RT, Streck EL, Zanetti MV, Ferreira GK, Diniz BS, Brunoni AR, Busatto GF, Gattaz WF and Machado-Vieira R: Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl). 232:245–250. 2015.PubMed/NCBI View Article : Google Scholar
21	Karlin A: Structure of nicotinic acetylcholine receptors. Curr Opin Neurobiol. 3:299–309. 1993.PubMed/NCBI View Article : Google Scholar
22	Lan YL, Wang X, Xing JS, Lou JC, Ma XC and Zhang B: The potential roles of dopamine in malignant glioma. Acta Neurol Belg. 117:613–621. 2017.PubMed/NCBI View Article : Google Scholar
23	Egleton RD, Brown KC and Dasgupta P: Nicotinic acetylcholine receptors in cancer: Multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci. 29:151–158. 2008.PubMed/NCBI View Article : Google Scholar
24	Ginzkey C, Stueber T, Friehs G, Koehler C, Hackenberg S, Richter E, Hagen R and Kleinsasser NH: Analysis of nicotine-induced DNA damage in cells of the human respiratory tract. Toxicol Lett. 208:23–29. 2012.PubMed/NCBI View Article : Google Scholar
25	Keiger CJ, Case LD, Kendal-Reed M, Jones KR, Drake AF and Walker JC: Nicotinic cholinergic receptor expression in the human nasal mucosa. Ann Otol Rhinol Laryngol. 112:77–84. 2003.PubMed/NCBI View Article : Google Scholar
26	Papke RL, Sanberg PR and Shytle RD: Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther. 297:646–656. 2001.PubMed/NCBI
27	Hirata N, Yamada S, Asanagi M, Sekino Y and Kanda Y: Nicotine induces mitochondrial fission through mitofusin degradation in human multipotent embryonic carcinoma cells. Biochem Biophys Res Commun. 470:300–305. 2016.PubMed/NCBI View Article : Google Scholar
28	Pastor N, Kaplan C, Dominguez I, Mateos S and Cortes F: Cytotoxicity and mitotic alterations induced by non-genotoxic lithium salts in CHO cells in vitro. Toxicol In Vitro. 23:432–438. 2009.PubMed/NCBI View Article : Google Scholar
29	Bhagwat SV, Vijayasarathy C, Raza H, Mullick J and Avadhani NG: Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem Pharmacol. 56:831–839. 1998.PubMed/NCBI View Article : Google Scholar
30	Cormier A, Morin C, Zini R, Tillement JP and Lagrue G: In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Res. 900:72–79. 2001.PubMed/NCBI View Article : Google Scholar
31	Miyazawa M, Kawauchi Y, Okuno Y and Oda Y: The novel assay method for nicotine metabolism to cotinine using high performance liquid chromatography. Chem Pharm Bull (Tokyo). 59:295–297. 2011.PubMed/NCBI View Article : Google Scholar
32	Rutledge SM and Asgharpour A: Smoking and liver disease. Gastroenterol Hepatol (NY). 16:617–625. 2020.PubMed/NCBI